Conference Coverage
Conference Coverage
Teen drug use hits lowest levels in decades
Illicit substance use among teenagers has dropped to the lowest rate in decades, with the exception of marijuana, according to results of the 2016...
Conference Coverage
Prenatal exposure to TNF inhibitors does not increase infections in newborns
WASHINGTON
Conference Coverage
First-in-kind study parsed risks of central lines in children
SAN DIEGO - Rising rates of pediatric venous thromboembolism in the United States underscore the need to carefully weigh the risks and benefits of...
Conference Coverage
VIDEO: SPIN tests hydroxyurea to prevent pediatric stroke in sickle cell disease
SAN DIEGO - Whether hydroxyurea can avert a first stroke in children with sickle cell disease is a question that may be answered by a soon-to-be-...
Conference Coverage
Wide variation seen in treatment of infantile spasms
HOUSTON – The types of diagnostic tests ordered and medication used for treatment of infantile spasms vary considerably, a large study of children...
Conference Coverage
Wrist-worn system detected convulsive seizures in home setting
HOUSTON – A wrist-worn device and smartphone-based alert system worn by a patient outside of the epilepsy monitoring unit for 3 months effectively...
Conference Coverage
Rate of mosaicism in parents of children with epileptic encephalopathy likely underestimated
HOUSTON – The rate of parental mosaicism in children with sporadic cases of epileptic encephalopathy and an apparent de novo mutation is believed...
Conference Coverage
Vitamin D supplementation recommended in all children, teens
Dr. Catherine Gordon recommends 600 IU of vitamin D daily for all healthy children and teens
Conference Coverage
VIDEO: Anti-CD22 CAR for R/R ALL impresses in early trial
SAN DIEGO – In a first-in-humans trial, chimeric antigen receptor (CAR) T-cell therapy directed against CD22 was safe, with minimal residual...
Conference Coverage
ASH: Hemophilia B gene therapy posts strong update
SAN DIEGO – Patients with hemophilia B who received a single 1-hour infusion of the gene transfer therapy SPK-9001 achieved steady-state factor IX...
Conference Coverage
VIDEO: Hemophilia B gene therapy maintains factor IX levels averaging 28%
SAN DIEGO – Patients with hemophilia B who received a single infusion of the gene transfer therapy SPK-9001 achieved steady-state factor IX...